MMedication Read More Breakthrough method gives ‘snapshot’ of a plant’s metabolic effectsFebruary 26, 2026 Scientists developed a new way to help understand what happens in the body when people consume a plant…
MMedication Read More GLP-1 Medications for Weight Loss: How to Get Started | NewsFebruary 26, 2026 Any licensed health care provider—including primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists,…
MMedication Read More Can GLP-1 Weight Loss Drugs Cause Scurvy? What to KnowFebruary 26, 2026 Share on PinterestReports of people developing scurvy while taking GLP-1 medications are on the rise. Milles Team/ShutterstockReports of…
MMedication Read More 1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market CrashFebruary 26, 2026 Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…
MMedication Read More Has Australia’s social media ban worked? The eSafety Commissioner is monitoring kids’ Ritalin use to find outFebruary 26, 2026 February 26, 2026 — 12:01am Save You have reached your maximum number of saved items. Remove items from…
MMedication Read More Fake Mounjaro pens supplied through UK online pharmacyFebruary 26, 2026 C+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the…
MMedication Read More Move Free Chiropractic has opened a new clinic in ElyFebruary 26, 2026 What is the name of your business? Move Free Chiropractic What do you do? We offer chiropractic services,…
MMedication Read More 1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market CrashFebruary 26, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
MMedication Read More Migraine pills ‘restore patient’s life’ as thousands benefit from first-ever tabletsFebruary 25, 2026 An NHS regulator highlighted the ‘rapid take-up’ of new migraine pills to stop a key protein which causes…
MMedication Read More FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of PresbyopiaFebruary 25, 2026 FDA PDUFA Goal Date Set for October 17, 2026 PITTSBURGH, Feb. 25, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS),…
MMedication Read More B.C. to distribute free nasal naloxone but experts wary of funding set to end next yearFebruary 25, 2026 Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology.…
MMedication Read More Severe side effects of taking Metformin drug prescribed to 120 million people worldwideFebruary 25, 2026 Said to be prescribed to over 120 million people around the globe, metformin is also commonly dropped by…